Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions

Thrombosis and Haemostasis

Volumn 107, Issue 5, 2012, Pages 875-883

  Park, Rojin ^a,b   Ping, Lifang ^b   Song, Jaewoo ^c   Hong, Sung Yu ^d   Choi, Tae Youn ^a   Choi, Jong Rak ^c   Gorkun, Oleg V ^b   Lord, Susan T ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Yonsei University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

module; Ala341; 'A a' interaction; Calcium binding; Dysfibrinogenemia; GPRP binding

Indexed keywords

BLOOD CLOTTING FACTOR 13A; FIBRINOGEN; FIBRINOGEN GAMMA; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; PLASMIN; PROTEIN VARIANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM BINDING; CONTROLLED STUDY; FIBRIN CLOT; FIBRIN POLYMERIZATION; FIBRINOGEN SYNTHESIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN STRUCTURE; SCANNING ELECTRON MICROSCOPY;

ALANINE; AMINO ACID SEQUENCE; ANIMALS; ASPARTIC ACID; BINDING SITES; BLOOD COAGULATION; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR XIIIA; FIBRINOGEN; FIBRINOGENS, ABNORMAL; FIBRINOLYSIN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE B; HUMANS; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; OLIGOPEPTIDES; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; THROMBIN; TRANSFECTION; VALINE;

EID: 84860504905     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-10-0731     Document Type: Article

References (31)

1. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem 1984; 53: 195-229.
2. Tennent GA, Brennan SO, Stangou AJ, et al. Human plasma fibrinogen is synthesized in the liver. Blood 2007; 109: 1971-1974.
3. Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992; 29: 177-188.
4. Medved L, Weisel JW. Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost 2009; 7: 355-359.
5. Lord ST. Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hema-tol 2007; 14: 236-241.
6. Cote HC, Lord ST, Pratt K P. gamma-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen. Blood 1998; 92: 2195-2212.
7. Everse SJ, Spraggon G, Doolittle RF. A three-dimensional consideration of variant human fibrinogens. Thromb Haemost 1998; 80: 1-9.
8. Pratt K P, Cote HC, Chung DW, et al. The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci USA 1997; 94: 7176-7181.
9. Shimizu A, Nagel GM, Doolittle RF. Photoaffinity labeling of the primary fibrin polymerization site: isolation and characterization of a labeled cyanogen bromide fragment corresponding to gamma-chain residues 337-379. Proc Natl Acad Sci USA 1992; 89: 2888-2892.
10. Song KS, Park NJ, Choi JR, et al. Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia. Clin Appl Thromb Hemost 2006; 12: 338-343.
11. Davis RL, Brennan SO. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. Thromb Haemost 2007; 98: 1136-1138.
12. Hanss M, Chevreaud C, French P, et al. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn). Thromb Haemost 2007; 98: 689-691.
13. Hogan KA, Lord ST, Okumura N, et al. A functional assay suggests that hetero-dimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV. Thromb Haemost 2000; 83: 592-597.
14. Okumura N, Gorkun OV, Lord ST. Severely impaired polymerization of recom-binant fibrinogen gamma-364 Asp --> His, the substitution discovered in a heterozygous individual. J Biol Chem 1997; 272: 29596-29601.
15. Gorkun OV, Veklich YI, Weisel JW, et al. The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. Blood 1997; 89: 4407-4414.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
17. Corley RB. A guide to methods in the biomedical sciences/Ronald B. Corley. Springer, New York; 2004.
18. Mullin JL, Gorkun OV, Binnie CG, et al. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release. J Biol Chem 2000; 275: 25239-25246.
19. Park R, Doh HJ, An SS, et al. A novel fibrinogen variant (fibrinogen Seoul II; Aal-phaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking. Blood 2006; 108: 1919-1924.
20. Bowley SR, Merenbloom BK, Okumura N, et al. Polymerization-defective fibri-nogen variant gammaD364A binds knob "A"peptide mimic. Biochemistry 2008; 47: 8607-8613.
21. Di Stasio E, Nagaswami C, Weisel JW, et al. Cl- regulates the structure of the fibrin clot. Biophys J 1998; 75: 1973-1979.
22. Yamazumi K, Doolittle RF. The synthetic peptide Gly-Pro-Arg-Pro-amide limits the plasmic digestion of fibrinogen in the same fashion as calcium ion. Protein Sci 1992; 1: 1719-1720.
23. Nieuwenhuizen W, Vermond A, Nooijen WJ, et al. Calcium-binding properties of human fibrin(ogen) and degradation products. FEBS Lett 1979; 98: 257-259.
24. Lounes KC, Ping L, Gorkun OV, et al. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b"interactions have a role in protofibril formation. Biochemistry 2002; 41: 5291-5299.
25. Kostelansky MS, Lounes KC, Ping LF, et al. Probing the gamma2 calcium-binding site: studies with gammaD298,301A fibrinogen reveal changes in the gamma294-301 loop that alter the integrity of the "a"polymerization site. Biochemistry 2007; 46: 5114-5123.
26. Lewis SD, Shields P P, Shafer JA. Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem 1985; 260: 10192-10199.
27. Laudano A P, Doolittle RF. Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. Science 1981; 212: 457-459.
28. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992; 63: 111-128.
29. Vu D, Neerman-Arbez M. Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins. J Thromb Haemost 2007; 5 (Suppl 1): 125-131.
30. Koopman J, Haverkate F, Briet E, et al. A congenitally abnormal fibrinogen (Vliss-ingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization. J Biol Chem 1991; 266: 13456-13461.
31. Terasawa F, Hogan KA, Kani S, et al. Fibrinogen Otsu I: A gammaAsn319,Asp320 deletion dysfibrinogen identified in an asymptomatic pregnant woman. Thromb Haemost 2003; 90: 757-758.